In agreement, a further study showed that elevated levels of ADAMTS6 shown by RNA-seq and validated by qRT-PCR, via NFATC2 upregulation, was demonstrated in a metastasized breast cancer cell line (Xu et al., 2021). The gene discussed is ADAMTS6; the disease is breast carcinoma.